• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续感染患者体内体液抗HCV/E2反应的异质性,表现为抗HCV/E2人单克隆抗体结合抑制模式的差异。

Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.

作者信息

Mancini N, Canducci F, Carletti S, Berardinelli E, Serafini G, Grieco A, Perotti M, Malcangi G, Danieli M G, Varaldo P E, Clementi M, Burioni R

机构信息

Institute of Microbiology, University of Ancona, Ancona, Italy.

出版信息

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):183-7.

PMID:14518720
Abstract

A complete understanding of the molecular features of humoral immune response could be of pivotal importance in the management of persistent viruses as HCV. In this study, 24 HCV-positive samples, characterized by classical virological parameters, are evaluated using a new assay for the quantitation of antibody subpopulations directed against discrete epitopes on surface glycoprotein E2, a key viral protein. The results, besides confirming the usefulness of this new approach, highlight the extreme heterogeneity of anti-HCV/E2 response as far as single epitopes are concerned. The specific epitopes under study are also demonstrated to be widely shared among different genotypes.

摘要

全面了解体液免疫反应的分子特征对于管理如丙型肝炎病毒(HCV)这样的持续性病毒可能至关重要。在本研究中,使用一种新的检测方法对24份以经典病毒学参数为特征的HCV阳性样本进行评估,该方法用于定量针对关键病毒蛋白表面糖蛋白E2上离散表位的抗体亚群。结果除了证实这种新方法的实用性外,还突出了就单个表位而言抗HCV/E2反应的极端异质性。所研究的特定表位还被证明在不同基因型之间广泛共享。

相似文献

1
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.持续感染患者体内体液抗HCV/E2反应的异质性,表现为抗HCV/E2人单克隆抗体结合抑制模式的差异。
J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):183-7.
2
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.针对丙型肝炎病毒E2糖蛋白的非中和性人抗体片段可调节人重组Fab的结合活性的中和作用。
Virology. 2001 Sep 15;288(1):29-35. doi: 10.1006/viro.2001.1014.
3
Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.抗病毒治疗对表位特异性抗丙型肝炎病毒E2(抗-HCV/E2)抗体的调节作用
J Med Virol. 2006 Oct;78(10):1304-11. doi: 10.1002/jmv.20704.
4
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.在慢性丙型肝炎病毒感染中,交叉反应性假病毒中和性抗包膜抗体与缺乏这种活性的抗体共存。
Virology. 2004 Oct 1;327(2):242-8. doi: 10.1016/j.virol.2004.06.042.
5
Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.广泛血清学检测后抗-HCV不确定样本中丙型肝炎病毒E2重组抗原抗体的检测及其与病毒血症的相关性。西班牙高危丙肝病毒传播献血者研究小组
Vox Sang. 1996;70(4):213-6.
6
Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).针对丙型肝炎病毒第二包膜糖蛋白(E2)的抗体反应的交叉反应性及临床影响。
J Med Virol. 2001 Sep;65(1):23-9.
7
Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.透析患者和慢性肝病患者中的丙型肝炎病毒感染:病毒血症依赖性抗E2抗体反应。
J Med Virol. 2004 Aug;73(4):529-35. doi: 10.1002/jmv.20122.
8
Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.两种源自重组Fab片段、靶向丙型肝炎病毒E2糖蛋白的广谱人单克隆IgG1的中和活性及动力学
New Microbiol. 2012 Oct;35(4):475-9. Epub 2012 Oct 1.
9
Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.利用酵母肽库对丙型肝炎病毒E2糖蛋白中B细胞免疫原性结构域进行表征和定位
Virology. 1994 Apr;200(1):246-55. doi: 10.1006/viro.1994.1182.
10
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.通过 repertoire 克隆和重组 Fab 片段的生成剖析人类针对丙型肝炎病毒 E2 糖蛋白的体液免疫反应。
Hepatology. 1998 Sep;28(3):810-4. doi: 10.1002/hep.510280331.

引用本文的文献

1
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.嵌合抗原受体(CAR)工程化T细胞重定向靶向丙型肝炎病毒(HCV)E2糖蛋白。
Gut. 2016 Mar;65(3):512-23. doi: 10.1136/gutjnl-2014-308316. Epub 2015 Feb 6.
2
Multiantibody strategies for HIV.针对艾滋病病毒的多抗体策略
Clin Dev Immunol. 2013;2013:632893. doi: 10.1155/2013/632893. Epub 2013 Jun 6.
3
Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?中和性干扰抗体:一种促进病毒逃逸的体液免疫功能障碍的“新”范例?
Viruses. 2012 Sep;4(9):1731-52. doi: 10.3390/v4091731. Epub 2012 Sep 24.
4
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.基于噬菌体展示的针对人类病原体的单克隆抗体克隆与优化策略。
Int J Mol Sci. 2012;13(7):8273-8292. doi: 10.3390/ijms13078273. Epub 2012 Jul 4.
5
Characterization of Anti-HCV Antibodies in IL-10-Treated Patients.IL-10 治疗患者的抗 HCV 抗体特征。
Viral Immunol. 2010 Aug;23(4):359-68. doi: 10.1089/vim.2009.0095.
6
Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein.一种针对丙型肝炎病毒E2蛋白的具有广泛交叉反应性和中和作用的人源单克隆抗体的鉴定。
J Virol. 2008 Jan;82(2):1047-52. doi: 10.1128/JVI.01986-07. Epub 2007 Nov 7.